Human immunodeficiency virus type 1 modulates telomerase activity in peripheral blood lymphocytes.

PubWeight™: 1.57‹?› | Rank: Top 4%

🔗 View Article (PMID 11133373)

Published in J Infect Dis on December 18, 2000

Authors

G Ballon1, L Ometto, E Righetti, A M Cattelan, S Masiero, M Zanchetta, L Chieco-Bianchi, De Rossi A

Author Affiliations

1: Department of Oncology and Surgical Sciences, Section of Oncology, AIDS Reference Center, University of Padova, Padova, Italy.

Articles citing this

Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytes. J Immunol (2008) 1.34

Accelerated biological ageing in HIV-infected individuals in South Africa: a case-control study. AIDS (2013) 1.20

Eradication of HIV-1 from the macrophage reservoir: an uncertain goal? Viruses (2015) 1.07

Latent membrane protein 1 of Epstein-Barr virus activates the hTERT promoter and enhances telomerase activity in B lymphocytes. J Virol (2008) 1.01

HIV-1 Vpr protein inhibits telomerase activity via the EDD-DDB1-VPRBP E3 ligase complex. J Biol Chem (2013) 0.91

HIV-1 induces telomerase activity in monocyte-derived macrophages, possibly safeguarding one of its reservoirs. J Virol (2012) 0.89

VprBP (DCAF1): a promiscuous substrate recognition subunit that incorporates into both RING-family CRL4 and HECT-family EDD/UBR5 E3 ubiquitin ligases. BMC Mol Biol (2013) 0.88

Premature aging and immune senescence in HIV-infected children. AIDS (2016) 0.78

Soluble CD163 is associated with shortened telomere length in HIV-infected patients. J Acquir Immune Defic Syndr (2014) 0.78

Apoptosis and telomeres shortening related to HIV-1 induced oxidative stress in an astrocytoma cell line. BMC Neurosci (2009) 0.78

Cross talk between EBV and telomerase: the role of TERT and NOTCH2 in the switch of latent/lytic cycle of the virus. Cell Death Dis (2015) 0.77

Effect of productive in vitro human immunodeficiency virus or simian immunodeficiency virus infection on telomerase activity in lymphoid and nonlymphoid cells. J Infect Dis (2002) 0.77

Short-term inhibition of TERT induces telomere length-independent cell cycle arrest and apoptotic response in EBV-immortalized and transformed B cells. Cell Death Dis (2016) 0.75

Articles by these authors

The long-term clinical course of acute deep venous thrombosis. Ann Intern Med (1996) 6.87

Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med (1992) 5.48

Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med (1995) 2.75

CD4: CD8 ratio and HIV infection: the "tap-and-drain' hypothesis. Immunol Today (1996) 2.19

Antigen detection, virus culture, polymerase chain reaction, and in vitro antibody production in the diagnosis of vertically transmitted HIV-1 infection. AIDS (1991) 1.97

B-cell activation and HIV-1 infection: deeds and misdeeds. Immunol Today (1990) 1.95

HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection. J Immunol (1989) 1.66

Premature ovarian failure in patients with autoimmune Addison's disease: clinical, genetic, and immunological evaluation. J Clin Endocrinol Metab (2011) 1.60

Immune reconstitution in human immunodeficiency virus type 1-infected children with different virological responses to anti-retroviral therapy. Clin Exp Immunol (2007) 1.55

Comparability and validity of two clinical scores in the early differential diagnosis of acute stroke. BMJ (1994) 1.49

Radiation-induced myelopathy in long-term surviving metastatic spinal cord compression patients after hypofractionated radiotherapy: a clinical and magnetic resonance imaging analysis. Radiother Oncol (2001) 1.45

Multiple AGAMOUS homologs from cucumber and petunia differ in their ability to induce reproductive organ fate. Plant Cell (1998) 1.40

Tumor outgrowth in peripheral blood mononuclear cell-injected SCID mice is not associated with early Epstein-Barr virus reactivation. Leukemia (2003) 1.40

Truncation of the human immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4+ cells. J Virol (1997) 1.34

Mitochondrial targeting of the p13II protein coded by the x-II ORF of human T-cell leukemia/lymphotropic virus type I (HTLV-I). Oncogene (1999) 1.34

Italian guidelines on rehabilitation treatment of adolescents with scoliosis or other spinal deformities. Eura Medicophys (2005) 1.34

Spontaneous in vitro production of virus-specific antibody by lymphocytes from HIV-infected subjects. Clin Immunol Immunopathol (1988) 1.30

CXC chemokines IP-10 and mig expression and direct migration of pulmonary CD8+/CXCR3+ T cells in the lungs of patients with HIV infection and T-cell alveolitis. Am J Respir Crit Care Med (2000) 1.27

In-vitro production of HIV-specific antibody in children at risk of AIDS. Lancet (1988) 1.22

Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection. J Clin Invest (1996) 1.20

Expression and characterization of proteins produced by mRNAs spliced into the X region of the human T-cell leukemia/lymphotropic virus type II. Virology (1995) 1.20

Intracellular trafficking of the human immunodeficiency virus type 1 Rev protein: involvement of continued rRNA synthesis in nuclear retention. AIDS Res Hum Retroviruses (1995) 1.19

Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. Ann Oncol (2006) 1.18

Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I. Proc Natl Acad Sci U S A (1986) 1.16

Identification of a 3 kb Alu-mediated BRCA1 gene rearrangement in two breast/ovarian cancer families. Oncogene (1999) 1.14

Does alcohol intake affect highly active antiretroviral therapy (HAART) response in HIV-positive patients? J Acquir Immune Defic Syndr (2000) 1.14

Evolution of human immunodeficiency virus type 1 in perinatally infected infants with rapid and slow progression to disease. J Virol (1997) 1.10

Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome. J Natl Cancer Inst Monogr (2001) 1.09

Seroprevalence of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 in several regions of Italy. J Hum Virol (1999) 1.09

Pattern of antibody response against the V3 loop in children with vertically acquired immunodeficiency virus type 1 (HIV-1) infection. AIDS Res Hum Retroviruses (1993) 1.09

Viral phenotype and host-cell susceptibility to HIV-1 infection as risk factors for mother-to-child HIV-1 transmission. AIDS (1995) 1.09

Reduced seroprevalence of Kaposi's sarcoma-associated herpesvirus (KSHV), human herpesvirus 8 (HHV8), related to suppression of Anopheles density in Italy. Med Vet Entomol (2003) 1.08

Vertical transmission of HIV-1: lack of detectable virus in peripheral blood cells of infected children at birth. AIDS (1992) 1.07

Moloney murine leukemia virus tolerance in anti-CD4 monoclonal antibody-treated adult mice. J Immunol (1991) 1.06

Co-receptor usage of HIV-1 primary isolates, viral burden, and CCR5 genotype in mother-to-child HIV-1 transmission. AIDS (2000) 1.05

CD8+ T lymphocytes in the lung of acquired immunodeficiency syndrome patients harbor human immunodeficiency virus type 1. Blood (1995) 1.05

Large genomic deletions inactivate the BRCA2 gene in breast cancer families. J Med Genet (2005) 1.04

Pectoral and femoral fasciae: common aspects and regional specializations. Surg Radiol Anat (2008) 1.02

HIV-1 induces down-regulation of bcl-2 expression and death by apoptosis of EBV-immortalized B cells: a model for a persistent "self-limiting" HIV-1 infection. Virology (1994) 1.02

Restriction of HIV type 1 infection in macrophages heterozygous for a deletion in the CC-chemokine receptor 5 gene. AIDS Res Hum Retroviruses (1999) 1.00

B cell activation during HIV-1 infection. II. Cell-to-cell interactions and cytokine requirement. J Immunol (1991) 1.00

Human T-lymphotropic virus type I transcriptional regulation by methylation. Cancer Res (1990) 1.00

Thymus-marrow cell interaction evaluated by PHA stimulation and graft versus host activity. Nature (1971) 1.00

In vitro studies of HIV-1 infection in thymic lymphocytes: a putative role of the thymus in AIDS pathogenesis. AIDS Res Hum Retroviruses (1990) 1.00

Rhodotorula glutinis-related meningitis. J Clin Microbiol (2001) 1.00

Hyaluronan within fascia in the etiology of myofascial pain. Surg Radiol Anat (2011) 0.98

Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeys. J Gen Virol (1997) 0.98

Inhibition of human T-cell leukemia virus type 2 Rex function by truncated forms of Rex encoded in alternatively spliced mRNAs. J Virol (1997) 0.98

The human T-cell lymphotropic virus type 1 Tof protein contains a bipartite nuclear localization signal that is able to functionally replace the amino-terminal domain of Rex. J Virol (1997) 0.98

P27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer. Ann Surg Oncol (2001) 0.96

The p13II protein of HTLV type 1: comparison with mitochondrial proteins coded by other human viruses. AIDS Res Hum Retroviruses (2000) 0.96

Hemianopia, hemianaesthesia, and hemiplegia after right and left hemisphere damage. A hemispheric difference. J Neurol Neurosurg Psychiatry (1993) 0.95

Identification of seven new BRCA1 germline mutations in Italian breast and breast/ovarian cancer families. Cancer Res (1996) 0.95

CD4 and CD8 T lymphocyte inheritance. Evidence for major autosomal recessive genes. Hum Genet (1999) 0.95

Coronary aneurysms in a case of Ehlers-Danlos syndrome. Jpn Heart J (1988) 0.95

A complete remission of recalcitrant molluscum contagiosum in an AIDS patient following highly active antiretroviral therapy (HAART) J Infect (1999) 0.94

Polymerase chain reaction and in-vitro antibody production for early diagnosis of paediatric HIV infection. Lancet (1988) 0.94

Diurnal and seasonal variations in the occurrence of stroke: a community-based study. Neuroepidemiology (1992) 0.94

A clinical evaluation of monoclonal (CA19-9, CA50, CA12-5) and polyclonal (CEA, TPA) antibody-defined antigens for the diagnosis of pancreatic cancer. Pancreas (1988) 0.93

Where is West Nile fever? Lessons learnt from recent human cases in northern Italy. Euro Surveill (2009) 0.93

Telomerase activity in chronic lymphoproliferative disorders of B-cell lineage. Br J Haematol (1999) 0.93

Perinatal infection by human immunodeficiency virus type 1 (HIV-1): relationship between proviral copy number in vivo, viral properties in vitro, and clinical outcome. J Med Virol (1991) 0.92

Replication and tropism of human immunodeficiency virus type 1 as predictors of disease outcome in infants with vertically acquired infection. J Pediatr (1993) 0.92

Polymorphisms in the CCR5 promoter region influence disease progression in perinatally human immunodeficiency virus type 1-infected children. J Infect Dis (2001) 0.92

Relationship between the V3 loop and the phenotypes of human immunodeficiency virus type 1 (HIV-1) isolates from children perinatally infected with HIV-1. J Virol (1995) 0.92

Transcriptional block of HTLV-I LTR by sequence-specific methylation. Virology (1991) 0.92

In vitro tenocyte metabolism in aging and oestrogen deficiency. Age (Dordr) (2012) 0.92

CD4 epitope masking by gp120/anti-gp120 antibody complexes. A potential mechanism for CD4+ cell function down-regulation in AIDS patients. J Immunol (1992) 0.92

Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: biological correlates of clinical outcome. Eur J Cancer (1999) 0.91

Directly observed therapy in HIV therapy: A realistic perspective? J Acquir Immune Defic Syndr (2000) 0.91

T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors. J Immunol (1982) 0.90

Tumours of the haematopoietic system. IARC Sci Publ (1979) 0.90

Phosphorylation of HIV-1 Rev protein: implication of protein kinase CK2 and pro-directed kinases. Biochem Biophys Res Commun (1996) 0.89

Sarcoidosis and HIV infection: a case report and a review of the literature. Postgrad Med J (2003) 0.89

HTLV-I/HTLV-II coinfection in an AIDS patient from São Paulo, Brazil. AIDS Res Hum Retroviruses (2000) 0.89

Mediastinitis due to cryptococcal infection: a new clinical entity in the HAART era. J Infect (2002) 0.89

HIV-1 infection of the thymus: evidence for a cytopathic and thymotropic viral variant in vivo. AIDS Res Hum Retroviruses (1995) 0.89

Dynamic Echomyography Shows That FES in Peripheral Denervation does not Hamper Muscle Reinnervation. Biomed Tech (Berl) (2013) 0.88

Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells. Gene Ther (2002) 0.88

Lack of association between androgen receptor CAG polymorphism and familial breast/ovarian cancer. Cancer Lett (2001) 0.88

Pseudotyping of Moloney leukemia virus-based retroviral vectors with simian immunodeficiency virus envelope leads to targeted infection of human CD4+ lymphoid cells. Gene Ther (1998) 0.88

Charcot-Marie-Tooth disease type I and related demyelinating neuropathies: Mutation analysis in a large cohort of Italian families. Hum Mutat (2001) 0.88

Frequency of a mutated CCR-5 allele (delta32) among Italian healthy donors and individuals at risk of parenteral HIV infection. AIDS Res Hum Retroviruses (1999) 0.88

Development of clinical guidelines: methodological and practical issues. Neurol Sci (2006) 0.88

Synthetic peptides from the principal neutralizing domain of human immunodeficiency virus type 1 (HIV-1) enhance HIV-1 infection through a CD4-dependent mechanism. Virology (1991) 0.87